Feed Preview

Alzheimer's Disease: Genetics

Alzheimer's Disease: Genetics diagram by Swaminathan et al, Wikimedia
Swaminathan et al, Wikimedia

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Top 20 most recent papers
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology

Meprin β cleaves TREM2 and controls its phagocytic activity on macrophages

FASEB Journal : Official Publication of the Federation of American Societies for Experimental BiologyApril 3, 2020
Dennis Kristopher BernerChristoph Becker-Pauly
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry

In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [125 I]Iodo-ASEM and [18 F]ASEM as Radiotracers of Homo- and Heteromeric α7 Nicotinic Acetylcholine Receptors

Molecules : a Journal of Synthetic Chemistry and Natural Product ChemistryApril 5, 2020
Cornelius K DonatJens D Mikkelsen
Biological Psychiatry

The β-Secretase BACE1 in Alzheimer's Disease

Biological PsychiatryApril 1, 2020
Harald HampelAndrea Vergallo
1
1
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology

Modulation of gamma oscillations as a possible therapeutic tool for neuropsychiatric diseases: A review and perspective

International Journal of Psychophysiology : Official Journal of the International Organization of PsychophysiologyApril 3, 2020
Daniel Strüber, Christoph S Herrmann
1
Frontiers in Pharmacology

Pathways Connecting Late-Life Depression and Dementia

Frontiers in PharmacologyApril 2, 2020
Christoph Linnemann, Undine E Lang
3
1
Neuropathology : Official Journal of the Japanese Society of Neuropathology

Histological characterization of interneurons in Alzheimer's disease reveals a loss of somatostatin interneurons in the temporal cortex

Neuropathology : Official Journal of the Japanese Society of NeuropathologyApril 2, 2020
Rachel WallerStephen B Wharton
1
1
BMC Medical Genomics

Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer's disease

BMC Medical GenomicsApril 4, 2020
Yurika UpadhyayaFor The Alzheimer's Disease Neuroimaging Initiative
Neurocase

Refractory epilepsy in PSEN 1 mutation (I83T)

NeurocaseApril 4, 2020
Saloua FraySamir Belal
Biology of Sex Differences

Neuroprotective and neurotoxic outcomes of androgens and estrogens in an oxidative stress environment

Biology of Sex DifferencesApril 1, 2020
Phong DuongRebecca L Cunningham
12
International Journal of Molecular Sciences

The Genetics of Alzheimer's Disease in the Chinese Population

International Journal of Molecular SciencesApril 3, 2020
Chen-Ling GanTae Ho Lee
F1000Research

The Continuing Evolution of Insulin-like Growth Factor Signaling

F1000ResearchApril 1, 2020
Steven A Rosenzweig
1
Journal of Ethnopharmacology

Neurodegenerative diseases and Withania somnifera (L.): An update

Journal of EthnopharmacologyApril 3, 2020
Nawab John Dar, MuzamilAhmad
2

See more papers from this feed

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-genetics/8db592be-740e-4d70-9f24-28ffc33168b7